Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity-Reference-Cited by-同舟云学术

Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity

Published:2015-06 Issue:6 Volume:62 Page:1398-1404
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Mueller Michaela,Thorell Anders,Claudel Thierry,Jha Pooja,Koefeler Harald,Lackner Carolin,Hoesel Bastian,Fauler Guenter,Stojakovic Tatjana,Einarsson Curt,Marschall Hanns-Ulrich,Trauner Michael

Publisher

Elsevier BV

Subject

Hepatology

Reference39 articles.

1. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

2. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice;Postic;J Clin Invest,2008

3. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c;Watanabe;J Clin Invest,2004

4. LXRS and FXR: the yin and yang of cholesterol and fat metabolism;Kalaany;Ann Rev Physiol,2006

5. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression;Claudel;Gastroenterology,2003

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Agonism of Liver and Gut FXR Prevents Cholestasis and Intestinal Atrophy in Parenterally Fed Neonatal Pigs;2024-09-07

2. Biotransformation of chenodeoxycholic acid by human intestinal fungi and the agonistic effects on FXR;Phytochemistry;2024-08

3. Bile acid metabolism in health and ageing-related diseases;Biochemical Pharmacology;2024-07

4. A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development;Biomedicine & Pharmacotherapy;2024-06

5. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-04-26